Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | GSK3A | P49840 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20278694 | 1.00 | ADRA2C (0.35) | ADRA2CGSK3AGSK3BMGLLKMT2A | |
| SCHEMBL19770696 | 0.87 | ADRA2C (0.32) | ADRA2CGSK3AGSK3BMGLLKMT2A | |
| SCHEMBL19711790 | 0.87 | ADRA2C (0.32) | ADRA2CGSK3AGSK3BMGLLKMT2A | |
| SCHEMBL19091628 | 0.80 | — | — | |
| SCHEMBL2661119 | 0.80 | — | — | |
| SCHEMBL10311254 | 0.79 | — | — | |
| SCHEMBL15215616 | 0.76 | ADRA2C (0.33) | ADRA2CGSK3AGSK3BMGLL | |
| SCHEMBL14493758 | 0.76 | — | — | |
| SCHEMBL20625906 | 0.76 | — | — | |
| SCHEMBL14140239 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 438 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240213479-A1 | ELECTRODE COMPOSITION, ELECTRODE SHEET FOR ALL-SOLID STATE SECONDARY BATTERY, ALL-SOLID STATE SECONDARY BATTERY, AND MANUFACTURING METHODS FOR ELECTRODE COMPOSITION, ELECTRODE SHEET FOR ALL-SOLID STATE SECONDARY BATTERY, AND ALL-SOLID STATE SECONDARY BATTERY | FUJIFILM CORPORATION (JP) | 2024-06-27 | — | — | US | disclosed |
| US-12018131-B2 | Polymerized in-situ hybrid solid ion-conductive compositions | Blue Current, Inc. (US) | 2024-06-25 | — | — | US | disclosed |
| US-12019369-B2 | Coloring composition, color filter, pattern forming method, solid-stage imaging element, and image display device | FUJIFILM CORPORATION (JP) | 2024-06-25 | — | — | US | disclosed |
| WO-2024111229-A1 | POROUS LOW DIELECTRIC POLYMER FILM | 日東電工株式会社 | 2024-05-30 | — | — | WO | disclosed |
| WO-2024105957-A1 | LAMINATE, AND METHOD FOR MANUFACTURING LAMINATE | 日東電工株式会社 | 2024-05-23 | — | — | WO | disclosed |
| WO-2023238515-A1 | COMPOSITION, LIQUID CRYSTAL POLYMER SHEET, LOW DIELECTRIC SUBSTRATE MATERIAL, AND WIRING CIRCUIT BOARD | 日東電工株式会社 | 2023-12-14 | — | — | WO | disclosed |
| US-20230355787-A1 | COMPOSITIONS AND METHODS FOR PREDICTING RESPONSE TO NAPI2B-TARGETED THERAPY | MERSANA THERAPEUTICS, INC. | 2023-11-09 | — | — | US | disclosed |
| US-11703758-B2 | Photosensitive composition for EUV light, pattern forming method, and method for manufacturing electronic device | FUJIFILM CORPORATION (JP) | 2023-07-18 | — | — | US | disclosed |
| US-20230183424-A1 | POLYAMIDE-IMIDE-BASED FILM, PREPARATION METHOD THEREOF, AND COVER WINDOW AND DISPLAY DEVICE COMPRISING THE SAME | MICROWORKS SOLUTIONS CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
| US-11581570-B2 | Polyurethane hybrid solid ion-conductive compositions | Blue Current, Inc. (US) | 2023-02-14 | — | — | US | disclosed |
| US-20070178405-A1 | Positive resist composition and method of pattern formation with the same | FUJI PHOTO FILM CO., LTD. | 2007-08-02 | — | — | US | disclosed |
| US-20070172769-A1 | Pattern forming method | FUJIFILM CORPORATION (JP) | 2007-07-26 | — | — | US | disclosed |
| US-7232638-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-06-19 | — | — | US | disclosed |
| US-20070128555-A1 | Novel ester compound, polymer, resist composition, and patterning process | CENTRAL GLASS CO., LTD. | 2007-06-07 | — | — | US | disclosed |
| US-7220520-B2 | Photosensitive resin compositions | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2007-05-22 | — | — | US | disclosed |
| US-7214465-B2 | Positive photosensitive composition | FUJIFILM CORPORATION (JP) | 2007-05-08 | — | — | US | disclosed |
| US-20070099111-A1 | Novel positive photosensitive polybenzoxazole precursor compositions | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. | 2007-05-03 | — | — | US | disclosed |
| US-20070065753-A1 | Positive resist composition for immersion exposure and pattern forming method using the same | FUJI PHOTO FILM CO., LTD. | 2007-03-22 | — | — | US | disclosed |
| US-7192681-B2 | Positive photosensitive composition | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| EP-0178903-A2 | Improved tellurium imaging composition and film including imide or ammonium salt | ENERGY CONVERSION DEVICES, INC. (US) | 1986-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355787-A1 | COMPOSITIONS AND METHODS FOR PREDICTING RESPONSE TO NAPI2B-TARGETED THERAPY | CD79B, NAP1L1, NAP1L4 | ADRA2C 3094/4885GSK3A 4268/4885GSK3B 3622/4885 |
| US-20070128555-A1 | Novel ester compound, polymer, resist composition, and patterning process | C9, RER1, ARF1 | ADRA2C 4412/4885GSK3A 3933/4885GSK3B 3874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.